La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
China Medical System Holdings Résultats passés
Passé contrôle des critères 2/6
China Medical System Holdings a connu une croissance annuelle moyenne de ses bénéfices de 4%, tandis que le secteur Pharmaceuticals a vu ses bénéfices augmenter de en hausse à 5.8% par an. Les revenus ont augmenté de en hausse à un taux moyen de 7.4% par an. Le rendement des capitaux propres de China Medical System Holdings est 8.6% et ses marges nettes sont de 19.8%.
Informations clés
4.0%
Taux de croissance des bénéfices
4.3%
Taux de croissance du BPA
| Pharmaceuticals Croissance de l'industrie | 5.6% |
| Taux de croissance des recettes | 7.4% |
| Rendement des fonds propres | 8.6% |
| Marge nette | 19.8% |
| Dernière mise à jour des bénéfices | 30 Jun 2024 |
Mises à jour récentes des performances passées
Recent updates
Little Excitement Around China Medical System Holdings Limited's (HKG:867) Earnings
Jul 15
An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 20% Undervalued
May 22China Medical System Holdings (HKG:867) Is Paying Out Less In Dividends Than Last Year
May 03We Think Shareholders May Want To Consider A Review Of China Medical System Holdings Limited's (HKG:867) CEO Compensation Package
May 02China Medical System Holdings' (HKG:867) Shareholders Will Receive A Smaller Dividend Than Last Year
Apr 19China Medical System Holdings (HKG:867) Is Paying Out Less In Dividends Than Last Year
Mar 29Not Many Are Piling Into China Medical System Holdings Limited (HKG:867) Stock Yet As It Plummets 35%
Mar 28China Medical System Holdings Limited's (HKG:867) Share Price Not Quite Adding Up
Dec 21Is China Medical System Holdings (HKG:867) A Risky Investment?
Dec 04If EPS Growth Is Important To You, China Medical System Holdings (HKG:867) Presents An Opportunity
Nov 15China Medical System Holdings (HKG:867) Will Pay A Larger Dividend Than Last Year At CN¥0.342
Aug 31China Medical System Holdings (HKG:867) Could Easily Take On More Debt
Aug 30Here's Why We Think China Medical System Holdings (HKG:867) Might Deserve Your Attention Today
Aug 07We Think China Medical System Holdings (HKG:867) Can Manage Its Debt With Ease
May 14Does China Medical System Holdings (HKG:867) Deserve A Spot On Your Watchlist?
Apr 26An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 47% Undervalued
Feb 05China Medical System Holdings (HKG:867) Seems To Use Debt Rather Sparingly
Dec 26If EPS Growth Is Important To You, China Medical System Holdings (HKG:867) Presents An Opportunity
Dec 08Is China Medical System Holdings (HKG:867) Using Too Much Debt?
Sep 14China Medical System Holdings (HKG:867) Is Paying Out A Larger Dividend Than Last Year
Aug 25Do China Medical System Holdings' (HKG:867) Earnings Warrant Your Attention?
Aug 15An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 49% Undervalued
Jul 08Should You Be Adding China Medical System Holdings (HKG:867) To Your Watchlist Today?
May 16Does China Medical System Holdings (HKG:867) Have A Healthy Balance Sheet?
Apr 10China Medical System Holdings (HKG:867) Is Increasing Its Dividend To HK$0.28
Mar 22If You Like EPS Growth Then Check Out China Medical System Holdings (HKG:867) Before It's Too Late
Feb 09Does China Medical System Holdings (HKG:867) Have A Healthy Balance Sheet?
Dec 25Should You Be Adding China Medical System Holdings (HKG:867) To Your Watchlist Today?
Nov 10China Medical System Holdings (HKG:867) Could Easily Take On More Debt
Sep 25China Medical System Holdings' (HKG:867) Dividend Will Be Increased To HK$0.32
Aug 26Here's Why We Think China Medical System Holdings (HKG:867) Is Well Worth Watching
Jul 30An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 33% Undervalued
Jun 27China Medical System Holdings (HKG:867) Could Easily Take On More Debt
Jun 14Does China Medical System Holdings (HKG:867) Deserve A Spot On Your Watchlist?
Apr 20Is There An Opportunity With China Medical System Holdings Limited's (HKG:867) 43% Undervaluation?
Mar 25Ventilation des recettes et des dépenses
Comment China Medical System Holdings gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 30 Jun 24 | 7,014 | 1,390 | 3,272 | 225 |
| 31 Mar 24 | 7,514 | 1,896 | 3,220 | 210 |
| 31 Dec 23 | 8,013 | 2,401 | 3,168 | 195 |
| 30 Sep 23 | 8,663 | 2,891 | 3,313 | 170 |
| 30 Jun 23 | 9,313 | 3,381 | 3,457 | 146 |
| 31 Mar 23 | 9,232 | 3,320 | 3,408 | 136 |
| 31 Dec 22 | 9,150 | 3,259 | 3,358 | 125 |
| 30 Sep 22 | 9,046 | 3,224 | 3,347 | 129 |
| 30 Jun 22 | 8,942 | 3,189 | 3,336 | 133 |
| 31 Mar 22 | 8,640 | 3,103 | 3,159 | 124 |
| 31 Dec 21 | 8,337 | 3,017 | 2,981 | 115 |
| 30 Sep 21 | 8,009 | 2,948 | 2,782 | 94 |
| 30 Jun 21 | 7,681 | 2,878 | 2,583 | 73 |
| 31 Mar 21 | 7,313 | 2,704 | 2,444 | 70 |
| 31 Dec 20 | 6,946 | 2,530 | 2,304 | 67 |
| 30 Sep 20 | 6,582 | 2,300 | 2,198 | 63 |
| 30 Jun 20 | 6,217 | 2,070 | 2,092 | 60 |
| 31 Mar 20 | 6,145 | 2,015 | 2,119 | 53 |
| 31 Dec 19 | 6,074 | 1,961 | 2,145 | 45 |
| 30 Sep 19 | 5,908 | 2,011 | 2,103 | 30 |
| 30 Jun 19 | 5,743 | 2,062 | 2,060 | 15 |
| 31 Mar 19 | 5,588 | 1,956 | 1,988 | 8 |
| 31 Dec 18 | 5,433 | 1,850 | 1,916 | 0 |
| 30 Sep 18 | 5,375 | 1,839 | 1,829 | 0 |
| 30 Jun 18 | 5,317 | 1,827 | 1,743 | 0 |
| 31 Mar 18 | 5,333 | 1,751 | 1,674 | 0 |
| 31 Dec 17 | 5,349 | 1,675 | 1,604 | 0 |
| 30 Sep 17 | 5,379 | 1,601 | 1,566 | 0 |
| 30 Jun 17 | 5,410 | 1,527 | 1,529 | 0 |
| 31 Mar 17 | 5,155 | 1,452 | 1,462 | 0 |
| 31 Dec 16 | 4,901 | 1,376 | 1,395 | 0 |
| 30 Sep 16 | 4,477 | 1,265 | 1,259 | 0 |
| 30 Jun 16 | 4,054 | 1,155 | 1,123 | 0 |
| 31 Mar 16 | 3,804 | 1,075 | 1,065 | 0 |
| 31 Dec 15 | 3,553 | 996 | 1,007 | 0 |
| 30 Sep 15 | 3,404 | 1,062 | 957 | 0 |
| 30 Jun 15 | 3,255 | 1,128 | 908 | 0 |
| 31 Mar 15 | 3,100 | 1,087 | 845 | 0 |
| 31 Dec 14 | 2,945 | 1,046 | 783 | 0 |
| 30 Sep 14 | 2,760 | 890 | 729 | 0 |
| 30 Jun 14 | 2,575 | 734 | 676 | 0 |
| 31 Mar 14 | 2,412 | 685 | 644 | 0 |
| 31 Dec 13 | 2,249 | 636 | 613 | 0 |
| 30 Sep 13 | 2,081 | 603 | 568 | 0 |
Des revenus de qualité: 867 a des bénéfices de haute qualité.
Augmentation de la marge bénéficiaire: Les marges bénéficiaires nettes actuelles de 867 (19.8%) sont inférieures à celles de l'année dernière (36.3%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: Les bénéfices de 867 ont augmenté de 4% par an au cours des 5 dernières années.
Accélération de la croissance: 867 a connu une croissance négative de ses bénéfices au cours de l'année écoulée, elle ne peut donc pas être comparée à sa moyenne sur 5 ans.
Bénéfices par rapport au secteur d'activité: 867 a enregistré une croissance négative de ses bénéfices ( -58.9% ) au cours de l'année écoulée, ce qui rend difficile la comparaison avec la moyenne du secteur Pharmaceuticals ( 3.8% ).
Rendement des fonds propres
ROE élevé: Le retour sur capitaux propres de 867 ( 8.6% ) est considéré comme faible.